BackPangaea Oncology, S.A. Overview

Pangaea Oncology, S.A. Receivables

Pangaea Oncology, S.A.'s receivables is $7.7M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$7.65M
↑ 3.02% YoYΔ $224725.00 vs prior year quarter

Peer trimmed avg / median

Loading

Pangaea Oncology, S.A. Receivables History

Loading

Pangaea Oncology, S.A. vs. peers: Receivables Comparison

Loading

Pangaea Oncology, S.A. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pangaea Oncology, S.A. (PANG.MC) FAQ

As of the most recent data (June 2026), PANG.MC shows a receivables of $7.7M. That compares with $7.4M in the prior-year period — up 3.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PANG.MC's receivables is now $7.7M (was $7.4M) — a 3.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pangaea Oncology, S.A. is outperforming or lagging.

Tracking PANG.MC's receivables over time shows whether Pangaea Oncology, S.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $7.7M That compares with $7.4M in the prior-year period — up 3.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Pangaea Oncology, S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $7.7M) with ownership activity and broader fundamentals.